Hyperion Capital Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,861
| Closed | -$87.9K | – | 62 |
|
|
2023
Q1 | $87.9K | Hold |
10,861
| – | – | 0.04% | 55 |
|
|
2022
Q4 | $171K | Hold |
10,861
| – | – | 0.08% | 54 |
|
|
2022
Q3 | $171K | Hold |
10,861
| – | – | 0.08% | 55 |
|
|
2022
Q2 | $152K | Hold |
10,861
| – | – | 0.07% | 56 |
|
|
2022
Q1 | $187K | Hold |
10,861
| – | – | 0.07% | 57 |
|
|
2021
Q4 | $158K | Buy |
+10,861
| New | +$158K | 0.04% | 54 |
|